Author(s): Park SY, Lee KW, Kang TS, Park SY, Lee KW, Kang TS, Park SY, Lee KW, Kang TS, Park SY, Lee KW, Kang TS
Abstract Share this page
Abstract Methylene blue is the first-choice treatment of methemoglobinemia, but it is not readily available in most Korean emergency departments because of an import suspension. An 84-year-old woman with dapsone-induced massive methemoglobinemia visited our emergency department for unclear mentality and cyanosis. Because methylene blue was not available, we intravenously administrated vitamin C (VC) for symptomatic methemoglobinemia, although VC is not a universally accepted treatment. Vitamin C (10 g intravenously) administered 6 hourly successfully treated the dapsone-induced methemoglobinemia and did not adversely affect renal functions. Thus,we recommend that if methylene blue is unavailable, 6 hourly intravenous administrations of 10 g of VC should be considered for dapsone-induced methemoglobinemia.
This article was published in Am J Emerg Med
and referenced in Journal of Clinical Toxicology